Use of a new combined vaccine in pediatric practices

Pediatrics

Volumn 118, Issue 2, 2006, Pages

  Freed, Gary L ^a,b   Cowan, Anne E ^a,b   Clark, Sarah J ^a,b   Santoli, Jeanne ^c   Bradley, Joel ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Premier Medical Group   (United States)

Author keywords

Combined; Immunization utilization; Pediarix; Vaccine

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS B VACCINE; PEDIATRIX; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PEDIARIX; VACCINE;

COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL PRACTICE; MEDICAL SOCIETY; PRIORITY JOURNAL; REVIEW; VACCINATION; ADULT; ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; DRUG UTILIZATION; ECONOMICS; FEE; INFANT; INFORMATION PROCESSING; MIDDLE AGED; PEDIATRICS; PROFESSIONAL PRACTICE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADULT; DATA COLLECTION; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG UTILIZATION; FEES AND CHARGES; FEMALE; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; MIDDLE AGED; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; POLIOVIRUS VACCINE, INACTIVATED; PROFESSIONAL PRACTICE; UNITED STATES; VACCINATION; VACCINES, ACELLULAR; VACCINES, COMBINED;

EID: 33748431114     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0114     Document Type: Review

References (27)

1. Centers for Disease Control and Prevention (CDC). FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined (PEDIARIX), for use in infants [published correction appears in MMWR Morb Mortal Wkly Rep. 2003;52:379]. MMWR Morb Mortal Wkly Rep. 2003;52:203-204
2. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Product approval information. Available at: www.fda.gov/cber/approvltr/hbHB100296L.htm. Accessed January 9, 2006
3. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Product approval information - licensing action. Available at: www.fda.gov/cber/products/hahbskb051101.htm. Accessed January 9, 2006
4. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Product approval information - licensing action. Available at: www.fda.gov/cber/approvltr/mmrvmer090605L.htm. Accessed January 9, 2006
5. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J. 1994;13:394-407
6. Lieu TA, Black SB, Sorel ME. Would better adherence to guidelines improve immunization rates? Pediatrics. 1996;98:1062-1068
7. National Vaccine Program Office. U.S. National Vaccine Plan. Washington, DC: Department of Health and Human Services. Available at: www.hhs.gov/nvpo/ vacc_plan/. Accessed January 9, 2006
8. American Academy of Pediatrics, Committee on Infectious Diseases. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Pediatrics. 1999;103:1064-1077
9. Centers for Disease Control and Prevention. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep. 1999;48(RR-5):1-30
10. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep. 2002;51(RR-2):1-35
11. Ward JI. Importance of new combination vaccines. Clin Pediatr (Phila). 2004;43:503-504
12. Shenkin BN. Combination vaccines [letter]. Am J Manag Care. 2003;9:526
13. Marcy SM. Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers. Am J Manag Care. 2003;9:314-320
14. Pichichero ME, Quick LS. Clinical evaluation of Pediarix: a new pediatric combination vaccine. Clin Pediatr (Phila). 2003;42:393-400
15. Pellissier JM, Coplan PM, Jackson LA. The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings. Am J Manag Care. 2000;6:1038-1044
16. Myerhoff AS, Weniger BG, Jacobs RJ. Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatr Infect Dis J. 2001;20:S57-S62
17. Goldfarb NI, Patel NM, Clarke JL. Improving quality by encouraging providers to use pediatric combination vaccines. Manag Care. 2005;6:3-12
18. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunization? A national telephone survey. Pediatrics. 2000;106:1097-1102
19. Davis MM, Ndiaye SM, Freed GL, Clark SJ. One year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract. 2003;16:363-371
20. Kolasa MS, Peterson TJ, Brink EW, Bulim ID, Stevenson JM, Rodewald LE. Impact of multiple injections on immunization rates among vulnerable children. Am J Prev Med. 2001;21:261-266
21. Woodkin KA, Rodewald LE, Humiston SG. Physician and parent opinions: are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med. 1995;149:845-849
22. Melman ST, Chawla T, Kaplan JM. Multiple immunizations: ouch! Arch Fam Med. 1994;3:615-618
23. Halperin BA, Eastwood BJ, Halperin SA. Comparison of parental and health care professional preferences for the acellular and whole cell pertussis vaccine. Pediatr Infect Dis J. 1998;17:103-110
24. Szilagyi PG, Rodewald LE, Humiston SG. Immunization practices of pediatricians and family physicians in the United States. Pediatrics. 1994;94:517-523
25. Lieu TA, Black SB. The hidden costs of infant immunization. Vaccine. 2000;19:33-41
26. Cabana MD, Aiken KD, Davis MM, Freed GL, Clark SJ. Effect of state vaccine-financing strategy on hepatitis B immunization in hospital nurseries. Ambul Pediatr. 2002;2:367-374
27. Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ. Influence of insurance status and vaccine cost on physicians' administration of a pneumococcal conjugate vaccine. Pediatrics. 2003;112:521-526